Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» breast cancer
breast cancer
Is Amgen's Prolia A Better Drug For Reducing Fractures And Recurrence After Breast Cancer?
Forbes
Fri, 12/11/15 - 11:29 am
Amgen
Prolia
breast cancer
4 Stocks Moving On Breast-Cancer News
Investors.com
Thu, 12/10/15 - 06:28 pm
breast cancer
neratinib
Puma Biotechnology
indoximod
NewLink Genetics
Seattle Genetics
SGN-LIV1A
Myriad Genetics
myChoice HRD
Pfizer Awards More Than $4 Million in Grants to Further Clinical Research in Advanced Breast Cancer for 2015
Yahoo
Tue, 12/8/15 - 10:12 am
Pfizer
R&D
breast cancer
grants
Novartis: Study shows copycat works just as well as Amgen drug
Yahoo/Reuters
Mon, 12/7/15 - 12:10 pm
Novartis
Amgen
Neulasta
Sandoz
generics
breast cancer
Invuity touts data from device-assisted mastectomy study
Mass Device
Fri, 09/18/15 - 10:13 pm
Invuity
devices
mastectomy
Eikon illuminated retractor system
breast cancer
Pfizer plots Ibrance expansion as early-stage breast cancer trial begins
Fierce Pharma
Thu, 08/27/15 - 11:48 am
Pfizer
Ibrance
breast cancer
Syndax banks an $80M crossover round for PhIII cancer drug
Fierce Biotech
Mon, 08/24/15 - 11:32 am
Syndax Pharma
IPOs
breast cancer
BioMarin sells its PhIII cancer drug to Medivation for $570M
Fierce Biotech
Mon, 08/24/15 - 11:22 am
Biomarin
Medivation
talazoparib
breast cancer
BRCA1
BRCA2
Pfizer's hot-selling Ibrance gets even hotter with new $710M sales estimate for 2015
Fierce Pharma Marketing
Mon, 08/3/15 - 04:59 pm
Pfizer
Ibrance
breast cancer
TapImmune Reports Robust Immune Responses Generated in 19 of 20 Evaluable HER2/neu Breast Cancer Patients
Yahoo
Tue, 06/23/15 - 10:53 am
TapImmune
HER2+ breast cancer
breast cancer
HER2/neu
vaccines
Pfizer's Ibrance Takes Another Giant Leap Forward
Investopedia
Tue, 06/2/15 - 09:03 am
Pfizer
Ibrance
ASCO
breast cancer
Oncothyreon Breast Cancer Drug Exits ASCO '15 With Good Buzz
TheStreet.com
Mon, 06/1/15 - 09:43 am
Oncothyreon
breast cancer
ASCO
ONT-380
HER2-positive metastatic breast cancer
Pfizer's breast cancer-fighter Ibrance posts stellar second-line survival data
Fierce Pharma
Sat, 05/30/15 - 05:28 pm
Pfizer
Ibrance
ASCO
breast cancer
Pfizer Announces $3 Million Grants Program to Further Clinical Research in Advanced Breast Cancer
Yahoo
Thu, 05/28/15 - 09:48 am
Pfizer
breast cancer
grants
R&D
advanced breast cancer
4 Pharmaceutical Companies Leading the Breast Cancer Fight
24/7 Wall St
Fri, 05/8/15 - 10:48 am
breast cancer
Merck
Bristol-Myers Squibb
Medivation
Pfizer
Patients With Advanced Breast, Lung, Esophageal, and Colorectal Cancers Respond to Immunomedics' Novel Antibody-Directed Chemotherapy After Failing Multiple Prior Standard Treatments
Yahoo
Mon, 04/20/15 - 05:15 pm
Immunomedics
chemotherapy
breast cancer
lung cancer
esophageal cancer
colorectal cancer
sacituzumab govitecan
Approved Pfizer breast cancer drug impresses in latest study
Yahoo/Reuters
Wed, 04/15/15 - 02:35 pm
Pfizer
breast cancer
Ibrance
Breast cancer drug, key to Nektar growth plans, fails clinical trial
Bizjournals.com
Tue, 03/17/15 - 07:23 pm
Nektar
NKTR-102
breast cancer
Can Pfizer's new breast cancer med really cruise to $4B and beyond?
Fierce Pharma Marketing
Tue, 02/24/15 - 07:00 pm
Pfizer
breast cancer
palbociclib
Pfizer breast cancer drug gets early FDA approval
Yahoo/AP
Wed, 02/4/15 - 09:07 am
Pfizer
palbociclib
HER-2 postive breast cancer
breast cancer
FDA
Pages
« first
‹ previous
…
14
15
16
17
18
19
20
21
22
…
next ›
last »